ADT three-lens brief
Evidence-based stock research on ADT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Underperforming SPY by 9.3pp over 30 days.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 9.3pp over 30 days.
- P/E of 9.7 — trading at a value multiple.
- Analyst mean target $8.23 — 17% above current (5 analysts).
- Debt-to-equity of 224% — balance-sheet-heavy.
ADT closed at $7.01 (+0.21%) as of 2026-09-11. Market cap: $5.12B. P/E (trailing) 9.7. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 9.7 — trading at a value multiple.; analyst mean target $8.23 — 17% above current (5 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 9.3pp over 30 days.. Last quarter: Revenue $1.31B, net income $154.00M, free cash flow $1.20B.
Why three lenses on ADT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ADTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ADT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ADT brief"></iframe>